Search
Now showing items 1-2 of 2
Trends of use of SGLT2 inhibitors in Qatar
(
Qatar University Press
, 2021 , Poster)
Background: Type 2 diabetes mellitus (T2DM) represents a growing health challenge in Qatar and worldwide. T2DM is associated with a high risk of cardiovascular (CV) morbidity and mortality, and progression of renal disease. ...
Comparative efficacy of empagliflozin versus placebo in the treatment of type 1 diabetes mellitus: A meta-analysis of randomized controlled trials
(
Uniwersytet Medyczny w Lublinie
, 2021 , Article)
The objective of this meta-analysis study was to evaluate the comparative efficacy of empagliflozin (25 mg) with placebo in the treatment and management of type 1 diabetes mellitus. This study is a meta-analysis, so an ...